K Walton

1.4k total citations
27 papers, 1.1k citations indexed

About

K Walton is a scholar working on Pharmacology, Cancer Research and Molecular Biology. According to data from OpenAlex, K Walton has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in K Walton's work include Carcinogens and Genotoxicity Assessment (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). K Walton is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Effects and risks of endocrine disrupting chemicals (6 papers). K Walton collaborates with scholars based in United Kingdom, United States and Netherlands. K Walton's co-authors include J.L.C.M. Dorne, A.G. Renwick, Eric Gruenstein, Wout Slob, Ron Walker, A. G. Renwick, Costas Ioannides, Maurice M. Coombs, José V. Castell and G. Kozianowski and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and International Journal of Pharmaceutics.

In The Last Decade

K Walton

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Walton United Kingdom 19 360 276 250 206 133 27 1.1k
Mohamed S. Abdel‐Rahman United States 20 535 1.5× 206 0.7× 228 0.9× 211 1.0× 66 0.5× 111 1.7k
Patrick D. Lilly United States 13 305 0.8× 220 0.8× 486 1.9× 399 1.9× 89 0.7× 21 1.9k
R R Miller United States 20 366 1.0× 507 1.8× 252 1.0× 268 1.3× 70 0.5× 38 1.5k
R. Michael McClain United States 22 382 1.1× 305 1.1× 228 0.9× 453 2.2× 46 0.3× 45 1.7k
Andreas P. Freidig Netherlands 23 340 0.9× 209 0.8× 141 0.6× 402 2.0× 105 0.8× 47 1.4k
Amy L. Roe United States 18 562 1.6× 326 1.2× 308 1.2× 592 2.9× 143 1.1× 41 1.8k
Greg Cosma United States 20 334 0.9× 397 1.4× 302 1.2× 872 4.2× 68 0.5× 38 1.8k
E. Richter Germany 26 386 1.1× 468 1.7× 188 0.8× 610 3.0× 68 0.5× 116 1.7k
Bert Spenkelink Netherlands 19 323 0.9× 170 0.6× 108 0.4× 296 1.4× 128 1.0× 36 1.2k
William O. Ward United States 20 456 1.3× 148 0.5× 102 0.4× 437 2.1× 38 0.3× 48 1.2k

Countries citing papers authored by K Walton

Since Specialization
Citations

This map shows the geographic impact of K Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Walton more than expected).

Fields of papers citing papers by K Walton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Walton. The network helps show where K Walton may publish in the future.

Co-authorship network of co-authors of K Walton

This figure shows the co-authorship network connecting the top 25 collaborators of K Walton. A scholar is included among the top collaborators of K Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Walton. K Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nep, E.I., Mohammed H. Mahdi, Adeola O. Adebisi, et al.. (2017). The influence of hydroalcoholic media on the performance of Grewia polysaccharide in sustained release tablets. International Journal of Pharmaceutics. 532(1). 352–364. 15 indexed citations
2.
Walton, K, J.L.C.M. Dorne, & A. G. Renwick. (2003). Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans. Food and Chemical Toxicology. 42(2). 261–274. 51 indexed citations
3.
Dorne, J.L.C.M., K Walton, & A.G. Renwick. (2003). Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors. Food and Chemical Toxicology. 41(2). 225–245. 38 indexed citations
4.
Dorne, J.L.C.M., K Walton, & A.G. Renwick. (2003). Human variability for metabolic pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine and sulphate conjugation). Food and Chemical Toxicology. 42(3). 397–421. 34 indexed citations
5.
Dorne, J.L.C.M., K Walton, & A.G. Renwick. (2003). Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food and Chemical Toxicology. 41(2). 201–224. 78 indexed citations
6.
Edler, Lutz, Kenneth A. Poirier, Michael L. Dourson, et al.. (2002). Mathematical modelling and quantitative methods. Food and Chemical Toxicology. 40(2-3). 283–326. 82 indexed citations
7.
Dorne, J.L.C.M., K Walton, Wout Slob, & A.G. Renwick. (2002). Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?. Food and Chemical Toxicology. 40(11). 1633–1656. 57 indexed citations
8.
Dorne, J.L.C.M., K Walton, & A.G. Renwick. (2001). Uncertainty factors for chemical risk assessment. Food and Chemical Toxicology. 39(7). 681–696. 79 indexed citations
9.
Dorne, J.L.C.M., K Walton, & A.G. Renwick. (2001). Human variability in glucuronidation in relation to uncertainty factors for risk assessment. Food and Chemical Toxicology. 39(12). 1153–1173. 46 indexed citations
10.
Walton, K, Maurice M. Coombs, Ron Walker, & Costas Ioannides. (2001). The metabolism and bioactivation of agaritine and of other mushroom hydrazines by whole mushroom homogenate and by mushroom tyrosinase. Toxicology. 161(3). 165–177. 13 indexed citations
11.
Renwick, A.G. & K Walton. (2001). The use of surrogate endpoints to assess potential toxicity in humans. Toxicology Letters. 120(1-3). 97–110. 12 indexed citations
12.
Walton, K, J.L.C.M. Dorne, & A.G. Renwick. (2001). Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Food and Chemical Toxicology. 39(7). 667–680. 69 indexed citations
13.
Walton, K, J.L.C.M. Dorne, & A.G. Renwick. (2001). Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation. Food and Chemical Toxicology. 39(12). 1175–1190. 48 indexed citations
14.
Renwick, A.G., J.L.C.M. Dorne, & K Walton. (2000). An Analysis of the Need for an Additional Uncertainty Factor for Infants and Children. Regulatory Toxicology and Pharmacology. 31(3). 286–296. 72 indexed citations
15.
Coombs, Maurice M., et al.. (2000). Bioactivation of the carcinogen 11-methoxy-16,17-dihydro-15H-cyclopenta[a]phenanthrene. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 465(1-2). 85–90. 4 indexed citations
16.
Walton, K, et al.. (2000). Fate of the Mushroom Hydrazine Agaritine in the Rat and Mouse. Nutrition and Cancer. 37(1). 55–64. 10 indexed citations
17.
Walton, K, Ron Walker, Johannes J.M. van de Sandt, et al.. (1999). The application of in vitro data in the derivation of the Acceptable Daily Intake of food additives. Food and Chemical Toxicology. 37(12). 1175–1197. 74 indexed citations
18.
Walton, K, Rheeda L. Walker, & Costas Ioannides. (1998). Effect of baking and freeze-drying on the direct and indirect mutagenicity of extracts from the edible mushroom Agaricus bisporus. Food and Chemical Toxicology. 36(4). 315–320. 15 indexed citations
19.
20.
Walton, K, Maurice M. Coombs, Ron Walker, & Costas Ioannides. (1997). Bioactivation of mushroom hydrazines to mutagenic products by mammalian and fungal enzymes. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 381(1). 131–139. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed S. Abdel‐Rahman Breakdown of academic impact, for papers by Patrick D. Lilly Breakdown of academic impact, for papers by R R Miller Breakdown of academic impact, for papers by R. Michael McClain Breakdown of academic impact, for papers by Andreas P. Freidig Breakdown of academic impact, for papers by Amy L. Roe Breakdown of academic impact, for papers by Greg Cosma Breakdown of academic impact, for papers by E. Richter Breakdown of academic impact, for papers by Bert Spenkelink Breakdown of academic impact, for papers by William O. Ward
Rankless by CCL
2026